Yesterday,
mareklamo and I brought
lilaboux and
ahltis to the vet for a checkup. The vet commented on how healthy lilaboux is for an 18-year old cat, and then asked if we would be willing to enroll her in a clinical trial for a nonsteroidal anti-inflammatory drug (Robenacoxib), sponsored by
Novartis Animal Health. They took some blood samples and X-rays to determine if
(
Read more... )
Comments 2
Reply
I'll look into this more before agreeing to the trial. The vet said it was a phase III trial, which implies that safety trials have been done -- I'm going to call the vet and confirm that, as well as request the incidence of side effects in the earlier studies.
Reply
Leave a comment